Latest Parkinson Stories

Van Andel Institute Research Symposium Showcases Latest Developments In Parkinson's Research

2012-09-20 06:30:54

GRAND RAPIDS, Mich., Sept. 20, 2012 /PRNewswire/ -- Van Andel Institute (VAI) hosts a scientific symposium September 19-20 that gathers some of the world's most noted experts in Parkinson's disease and reinforces the region's growing reputation in the field of Parkinson's research. Grand Challenges in Parkinson's Disease features experts from a dozen nations including Australia, Malaysia and Sweden. The purpose of the event is to showcase the latest research in the field and to...

National Parkinson Foundation Gives Fundraising a Novel Twist

2012-09-12 02:27:44

--Dutch Island Author Donating Proceeds of Book Sales-- MIAMI, Sept. 12, 2012 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) is entangled in a mystery - and the national organization is glad of it. A just-released mystery novel titled Dutch Island is generating attention - and money - for NPF. A Parkinson's disease patient and his wife "star" in the comedic thriller that channels all proceeds from its print edition sales to the foundation. "This is a...

Communities to Unite at 13th Carnegie Center 5K and Fun Run in Support of the Parkinson's Community

2012-08-30 06:24:28

KINGSTON, N.J., Aug. 30, 2012 /PRNewswire-USNewswire/ -- Together with the Parkinson's community, hundreds of local runners and walkers have signed up for the 2012 Carnegie Center 5K and 1-Mile Fun Run for The Parkinson Alliance (CC5K), which will take place on Saturday, September 22nd in Princeton. This road race offers an abundance of amenities to a broad range of supporters. In addition to a USATF Certified 5K, multiple communities are drawn together to raise funds and...

UCB Launches Neupro® in the U.S. to treat Parkinson's Disease and Restless Legs Syndrome

2012-07-15 18:20:20

BRUSSELS and ATLANTA, July 16, 2012 /PRNewswire/ -- UCB announced today that Neupro(®) (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro(®) was approved by the U.S Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome. Neupro(®) improves motor function and activities of daily living in patients with PD and provides...

Parkinson's Drug Research Improves With Patient-Derived Stem Cells

2012-07-05 10:29:41

NIH-funded study shows cells from different patients have unique drug responses Researchers have taken a step toward personalized medicine for Parkinson's disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments. The study was funded by the National Institutes of Health. The researchers collected skin cells from patients with genetically inherited forms of Parkinson's and reprogrammed those cells into neurons. They...

18th Annual Parkinson's Unity Walk Raises More Than $1.5 Million in Support of Parkinson's Research

2012-05-02 10:26:26

KINGSTON, N.J., May 2, 2012 /PRNewswire/ -- The 18th Annual Parkinson's Unity Walk (PUW), held on Saturday, April 28, 2012 in New York City's Central Park, raised more than $1.5 million thus far and united 10,000 walkers, The Parkinson Alliance announced today. The event, kicked-off by Michael J. Fox, drew a record number of 527 registered teams participating in the PUW's 18 year history to help raise funds for Parkinson's disease (PD) research. The funds raised are distributed...

New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease

2012-04-26 06:26:07

ATLANTA, April 26, 2012 /PRNewswire/ -- Insights into the effects of Neupro(®) (rotigotine transdermal system) on common non-motor symptoms of Parkinson's disease (PD) were presented today at the 64th AAN Annual Meeting in New Orleans, LA. A post-hoc analysis of data from five, randomized, double-blind, placebo-controlled trials investigated the effect of rotigotine transdermal system on neuropsychiatric features and fatigue in patients with PD. Improvements were observed...

Researchers Seek Additional Participants for Landmark Parkinson's Disease Study

2011-12-19 11:24:00

Northwestern is among the top enrollment sites for international, five-year study CHICAGO, Dec. 19, 2011 /PRNewswire-USNewswire/ -- Nearly 1.5 million Americans have Parkinson's disease, with another 50,000 to 60,000 cases diagnosed each year. Parkinson's is a neurological disease that progresses over time, yet there is currently no definitive diagnosis or cure. In hopes of advancing research, individuals from across the country are volunteering to help scientists gather...

23andMe Discovers Genetic Variant That May Protect Those At High Risk For Parkinson’s Disease

2011-10-26 00:31:39

The Scripps Research Institute, funded by The Michael J. Fox Foundation, Will Further Investigate the SGK1 Gene – A First Step Toward Developing Possible Treatments for Parkinson’s Disease 23andMe, Inc., a leading personal genetics company, has announced the first-time discovery of the potentially protective nature of the gene serum/glucocorticoid regulated kinase 1 (SGK1) which appears to be protective against a high-risk leucine-rich repeat kinase 2 (LRRK2) mutation for Parkinson’s...

The National Parkinson Foundation Marks Hispanic Heritage Month With New Spanish Toll-Free Helpline, Brochure, Resources

2011-10-04 08:00:00

--Survey Shows Most Hispanics With Early Parkinson's Signs Would Wait To See Doc-- MIAMI, Oct. 4, 2011 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) announced today a campaign to reach the Hispanic community about early warning signs of Parkinson's disease (PD) with two key features: a bilingual, toll-free Helpline 1-800-4PD-INFO (1-800-473-4636), where health specialists answer caller questions about PD in both English and Spanish, and, a new, free brochure in Spanish...